• Explore /
  • Poster
  • / A phase II study of M6620 in combination with carboplatin compared with docetaxel in combination with carboplatin in metastatic castration-resistant prostate cancer.

A phase II study of M6620 in combination with carboplatin compared with docetaxel in combination with carboplatin in metastatic castration-resistant prostate cancer.

Abstract Poster

Authors

null

Atish Dipankar Choudhury

Dana-Farber Cancer Institute, Boston, MA

Atish Dipankar Choudhury , Wanling Xie , Mamta Parikh , Daniel Lee , Elizabeth R. Kessler , David Johnson Einstein , Bose Kochupurakkal , Kent William Mouw , Eliezer Mendel Van Allen , L. Austin Doyle , Alan D. D'Andrea , Mary-Ellen Taplin , Geoffrey Shapiro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03517969

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr TPS252)

Abstract #

TPS252

Poster Bd #

N18

Abstract Disclosures

Similar Posters

First Author: Atish Dipankar Choudhury

First Author: Atish Dipankar Choudhury

First Author: Johann S. De Bono

First Author: Johann S. De Bono